Surbhi Sidana, MD, MBBS, director of the Myeloma Disease Focused Group at Stanford University, provides a reintroduction to ...

In the largest study of its kind, researchers from The University of Texas MD Anderson Cancer Center identified three ...

The new study, funded in part by the National Institutes of Health and published June 18 in Cell Chemical Biology, showed ...

Large-scale metabolomic analyses of pan-cancer cell line panels have provided significant insights into the relationships between metabolism and cancer cell biology. Here, we took a pathway-centric ...

Our prior findings demonstrated that the combination of autologous NK cells with the PD-1 antibody (Sintilimab), offered promising efficacy in NSCLC patients who failed the first-line platinum-based ...